The substances we treat and include family integration at The Grove Estate are alcohol, opioids (e.g., heroin, prescription painkillers), benzodiazepines (e.g., Xanax, Valium),and Stimulants (e.g., cocaine, meth). The drugs that are treated during the residential detox program at The Grove Estate in Indiana are:
Alcohol
As reported by the CDC’s Behavioral Risk Factor Surveillance System (BRFSS), 50.0% of Indiana adults reported current alcohol use in 2020 compared to a national rate of 52.4%.
Opioids
Since 2017, opioid partial agonist prescriptions written by Indiana practitioners have risen by 138%, growing from 362,504 to 862,198. Similarly, prescriptions dispensed by Indiana pharmacies increased by 115.8%, from 408,654 to 891,151, as revealed by the Indiana State Government’s “Progress Report”.
Benzodiazepines
Benzodiazepine addiction accounts for a relatively small portion of substance use treatment admissions in Indiana when compared to opioids or methamphetamine. However, it remains a serious concern due to its frequent involvement in polysubstance abuse and its contribution to overdose risk. Nationally, benzodiazepine use is more prevalent than previously understood, with nearly 20% of all use considered misuse.
Stimulants
Frequently abused stimulants range from illicit drugs such as cocaine, crack cocaine, and methamphetamine to prescription medications like Adderall, Ritalin, and other amphetamine-based products. In State Fiscal Year (SFY) 2023, approximately 11% of all substance use treatment admissions in Indiana reported cocaine use as a primary, secondary, or tertiary substance—consistent with the previous year. Among these, 4% of treatment episodes identified cocaine as the primary substance of use, also unchanged from the prior year, according to the Indiana Division of Mental Health and Addiction.